Myovant Sciences Ltd.
MYOV
MYOV was delisted on the 9th of March, 2023.
31 hedge funds and large institutions have $342M invested in Myovant Sciences Ltd. in 2018 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 7 increasing their positions, 5 reducing their positions, and 8 closing their positions.
40% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 5
28% more capital invested
Capital invested by funds: $267M → $342M (+$74.3M)
3% less funds holding
Funds holding: 32 → 31 (-1)
13% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 8
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Janus Henderson Group
London,
United Kingdom
|
+$24.5M |
| 2 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
+$22.5M |
| 3 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$22.2M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$4.28M |
| 5 |
Millennium Management
New York
|
+$1.85M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$9.7M |
| 2 |
D.E. Shaw & Co
New York
|
-$7.45M |
| 3 |
Adage Capital Partners
Boston,
Massachusetts
|
-$3.71M |
| 4 |
TCM
Tekla Capital Management
Boston,
Massachusetts
|
-$3.2M |
| 5 |
EU
Emory University
Atlanta,
Georgia
|
-$1.16M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Bank of America
Charlotte,
North Carolina
| $37K | -$35.8K | -1,640 | -50% |
|
27
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| $30K | +$961 | +44 | +3% |
|
|
TRCT
28
Tower Research Capital (TRC)
New York
| $5K | +$4.37K | +200 | New |
|
|
SBL
29
Sargent Bickham Lagudis
Boulder,
Colorado
| $5K | +$4.7K | +215 | New |
|
30
BNP Paribas Financial Markets
Paris,
France
| $2.29K | – | – | – |
|
|
ML
31
McAdam LLC
Philadelphia,
Pennsylvania
| $1K | – | – | – |
|
|
32
D.E. Shaw & Co
New York
| – | -$7.45M | -350,000 | Closed |
|
|
TCM
33
Tekla Capital Management
Boston,
Massachusetts
| – | -$3.2M | -150,471 | Closed |
|
34
DZ Bank
Frankfurt Am Main,
Germany
| – | -$459K | -21,599 | Closed |
|
|
SKK
35
Shepherd Kaplan Krochuk
Boston,
Massachusetts
| – | -$248K | -11,637 | Closed |
|
36
Goldman Sachs
New York
| – | -$201K | -9,444 | Closed |
|
37
UBS Group
Zurich,
Switzerland
| – | -$22K | -1,025 | Closed |
|
|
MAM
38
Meeder Asset Management
Dublin,
Ohio
| – | -$2K | -80 | Closed |
|
MYOV Hedge Fund Activity: Q2 2018 in Review
31 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Myovant Sciences Ltd. (MYOV) for Q2 2018, worth a combined $342M — up 28% from $267M a quarter earlier.
Sellers outnumbered buyers: 8 funds closed out of MYOV and 7 opened new positions — a net loss of 1 holder — while 5 trimmed existing stakes and 7 added.
The largest buyer was Janus Henderson Group, opening a new position worth an estimated $24.5M. The largest seller was BlackRock, cutting an estimated $9.7M.
- 31 institutional investors held Myovant Sciences Ltd. (MYOV) as of Q2 2018, down from 32 in Q1 2018.
- Funds reported $342M of Myovant Sciences Ltd. stock for Q2 2018, up 28% quarter-over-quarter.
- 7 funds opened new Myovant Sciences Ltd. positions in Q2 2018 and 8 closed out, a net change of -1 holder.
- The largest Myovant Sciences Ltd. buyer in Q2 2018 was Janus Henderson Group, an estimated $24.5M added.
- The largest Myovant Sciences Ltd. seller in Q2 2018 was BlackRock, an estimated $9.7M sold.
Based on aggregated 13F filings for Q2 2018.